Reported revenue for the fourth quarter reached $1.9 billion, representing a 2% increase year-over-year. However, non-GAAP net income declined to $78 million, or $0.50 per share, from $89 million in the prior-year period. Both figures fell short of consensus analyst estimates, indicating potential headwinds not fully priced into market expectations.
Cardano retested the $0.25 mark like it was a mandatory family reunion-awkward, predictable, and everyone pretending they’re fine. But beneath the surface, it’s like a game of poker where everyone’s holding a royal flush. Long-term traders, those brave souls who’ve never owned a smartphone, are still betting on the idea that Cardano might one day be worth more than a bag of stale crackers.
The focus of attention, as it invariably is, rested upon the entity known as ‘Nvidia.’ Its pronouncements—a series of projected revenues, presented as irrefutable truths—elicited a rally. It is a curious phenomenon, this power to shape reality through the mere declaration of intent. Other entities similarly attuned to the currents of artificial intelligence – ‘Taiwan Semiconductor Manufacturing,’ ‘Dell Technologies,’ and ‘Micron’ – experienced corresponding, if less dramatic, ascensions. One wonders if these are genuine reflections of value, or merely echoes within the labyrinthine corridors of the market.
Cava reported fourth-quarter revenue of $272.8 million, representing a year-over-year increase of 21.2%. This growth appears attributable to both new store openings and incremental sales at existing locations. The company added 24 stores in the quarter, bringing the total store count to 439 as of December 28. While topline growth is encouraging, a granular assessment of unit economics is crucial.
The broader market, as is its custom, presented a mixed tableau. The S&P 500, with a gain of 0.82%, settled at 6,947, while the Nasdaq Composite, ever the more spirited of the two, ascended 1.26% to reach 23,152. Within the pharmaceutical realm, the currents flowed in different directions. Eli Lilly, a competitor of long standing, experienced a modest decline, closing at $1,028.83, down 1.28%. Novartis, however, remained relatively stable, ending the day at $166.85, a slight subtraction of 0.16%.
The company registered net sales of $17.7 billion – a figure that, upon closer inspection, is merely a larger iteration of $17.6 billion, much like an infinite series approaching a finite sum. Comparable sales rose by 5%, mirroring the full-year performance, a symmetry that might delight a geometer, but leaves the financial analyst yearning for asymmetry – for a signal, however faint, of genuine divergence. Net income, adhering to the generally accepted principles of accounting – a system of conventions as arbitrary as the placement of books in a library – reached $1.8 billion, translating to $1.58 per share, a 28% increase. Adjusted earnings, a construct designed to filter out the inconvenient truths of reality, yielded $1.43 per share, a 16% improvement.
Yesterday saw Bitcoin ascend by approximately 7.7%. Consequently, the overall market capitalization of digital currencies rose by a similar margin – 7.5%. This correlation is not evidence of a healthy, independent market, but rather a symptom of its immaturity. The tail, for the moment, wags the dog.
As of 5:03 p.m. ET, the shares were up a perfectly acceptable 2.2% from the closing price of $195.56. Not a fortune, naturally, but enough to keep the champagne on ice, just in case.
Nvidia, a name now uttered with the same reverence (and, I suspect, the same anxieties) as alchemists of old, is, of course, at the heart of this burgeoning spectacle. They are known, naturally, for conjuring the very foundations of these digital minds – the large language models, the LLMs, as they are called. But to believe they will rest on this accomplishment alone would be a grave error. No, they have turned their gaze to the art of inference – the relentless answering of questions, the tireless processing of data. Their Nvidia Inference Microservices, prebuilt and optimized, are like a legion of diligent clerks, each attending to a specific query.
The quarterly pronouncements from the company have, of late, become something of an event. And Mr. Jensen Huang, Nvidia’s CEO, has just delivered the latest dispatch. A remarkably robust one, as it happens.